文献速递关节外科

多孔钽杯与其他非骨水泥设计在翻修髋关节置换术后再翻修风险是否有差异

Does the Risk of Rerevision Vary Between Porous Tantalum Cups and Other Cementless Designs After Revision Hip Arthroplasty?
PubMed 文献 · Clin Orthop Relat Res · 2017-06-23

该研究联合澳大利亚与瑞典国家关节登记系统,纳入2442例首次THA翻修使用多孔钽杯和4401例使用其他非骨水泥杯的病例,比较7年无再翻修生存率及以假体周围感染(PJI)为终点的生存率。结果显示两组无再翻修生存率(86% vs 87%,p=0.85)和PJI再翻修生存率(97% vs 97%,p=0.64)均无显著差异,亚组分析结果不变。作者结论认为多孔钽杯在首次THA翻修中的假体生存与其他非骨水泥杯相似,未观察到既往所提示的感染相关再翻修获益。

要点

  • 多孔钽杯组7年无再翻修生存率86%,其他非骨水泥杯组87%,两组无显著差异(p=0.85)。
  • 以PJI再翻修为终点,两组7年生存率均为97%(p=0.64),无显著差异。
  • 排除使用加强块或仅分析骨关节炎及无菌性松动亚组后,结果不变。

核心结论

  • 首次THA翻修中多孔钽杯的假体生存与其他非骨水泥杯对照组相似。
  • 就现有数据而言,未能将感染相关再翻修生存获益归因于多孔钽杯组,与早期研究提示不同。
  • 需要结合髋臼骨缺损数据、宿主合并症因素及更长随访的进一步研究来证实或反驳这些结果。

研究设计与样本

  • 澳大利亚与瑞典国家关节登记系统的协作研究。
  • 纳入2442例首次THA翻修使用多孔钽杯和4401例首次THA翻修使用其他非骨水泥杯的病例。
  • 患者平均年龄69岁(范围19-97岁),女性3754例(55%)。
  • 多孔钽杯组平均随访3.0年(SD ±2.1年),非骨水泥对照组平均随访3.4年(SD ±2.3年)。
  • 多孔钽杯组伴随股骨柄翻修更常见(43% vs 36%),并对多孔钽加强块使用及骨关节炎初次置换、无菌性松动首次翻修亚组进行了分析。

主要发现

  • 7年内因任何原因再翻修的Kaplan-Meier生存率:多孔钽杯组86%(95%CI 85%-89%)vs 非骨水泥对照组87%(95%CI 85%-89%),p=0.85。
  • 以PJI为终点的7年总体生存率:多孔钽杯组97%(95%CI 95%-98%)vs 非骨水泥对照组97%(95%CI 96%-98%),p=0.64。
  • 排除使用加强块的病例或分析骨关节炎初次置换及无菌性松动首次翻修亚组,结果不变。

关键数值与推荐

  • 7年无再翻修生存率多孔钽杯组86%(95%CI 85%-89%),非骨水泥对照组87%(95%CI 85%-89%),p=0.85。
  • 7年PJI再翻修生存率多孔钽杯组97%(95%CI 95%-98%),非骨水泥对照组97%(95%CI 96%-98%),p=0.64。
  • 证据等级:Level III,治疗性研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要结合髋臼骨缺损数据、更深入了解宿主合并症因素及更长随访的进一步研究来证实或反驳这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Earlier results with porous tantalum acetabular cups in revision THA generally have been favorable. Recently there has been some evidence presented that porous tantalum cups might decrease the risk of rerevision in the setting of revision hip surgery performed owing to prosthetic joint infection (PJI). As the data supporting this assertion come from a study with a limited study population, examining this issue with a large registry approach may be enlightening. QUESTIONS/PURPOSES: By combining results from two large, national registries, we asked: (1) Do porous tantalum cups show improved survival after revision THA compared with other cementless designs? (2) Does the use of porous tantalum cups influence survivorship when rerevision for PJI is the endpoint? METHODS: A total of 2442 first-time THA revisions with porous tantalum cups and 4401 first-time revisions with other uncemented cups were included in this collaborative study between the Australian and Swedish national joint registries. The mean age of the patients was 69 years (range, 19-97 years), 3754 (55%) of the patients were women, and the mean followup for the porous tantalum and uncemented control groups were 3.0 years (SD, ± 2.1 years) and 3.4 years (SD, ± 2.3 years), respectively. Concomitant stem revision was more common in the porous tantalum group (43% versus 36%). The use of porous tantalum augments also was analyzed as a proxy for more complex acetabular reconstructions. In an attempt to further reduce selection bias, we performed subgroup analysis for primary operations attributable to osteoarthritis and first revision attributable to aseptic loosening. RESULTS: Kaplan-Meier survivorship with rerevisison for any reason up to 7 years was comparable between the porous tantalum cup group and the uncemented cup control group (86% [95% CI, 85%-89%] and 87% [95% CI, 85%-89%], respectively; p = 0.85) and the overall survivorship up to 7 years with a second revision for PJI as the endpoint (97% [95% CI, 95%-98%] and 97% [95% CI, 96%-98%], respectively; p = 0.64). Excluding procedures where augments had been used or studying primary osteoarthritis and first revision owing to aseptic loosening subgroups did not change this result. CONCLUSIONS: Implant survival for a porous tantalum cup in first-time THA revision was similar to the survival of the uncemented cup control group. With the numbers available, no benefit in survival with rerevision for infection as the endpoint could be ascribed to the porous tantalum cup group, as has been suggested by earlier work. Further studies with acetabular bone deficiency data, greater insight into host comorbidity factors, and a longer followup are needed to corroborate or refute these results. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Laaksonen I, Lorimer M, Gromov K, et al. Does the Risk of Rerevision Vary Between Porous Tantalum Cups and Other Cementless Designs After Revision Hip Arthroplasty? Clin Orthop Relat Res. 2017. PMID: 28646360. doi:10.1007/s11999-017-5417-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。